Antenatal corticosteroids are now established as one of the cornerstones of therapy in the prevention of neonatal morbidity and mortality prior to preterm birth. Although this practice is widely accepted, a significant number of controversies exist. This review explores the knowledge gaps regarding the use of antenatal corticosteroids in the preterm, late preterm and term populations. Furthermore, the role of antenatal corticosteroids in special populations, such as diabetes, multiple pregnancies and periviable gestations, where high‐quality data from randomized controlled trials are lacking, is also considered.

中文翻译：

---

产前皮质类固醇治疗的争议

产前皮质类固醇现已被确立为预防早产前新生儿发病率和死亡率的治疗基石之一。尽管这种做法已被广泛接受，但仍存在大量争议。本综述探讨了在早产、晚期早产和足月人群中使用产前皮质类固醇的知识差距。此外，还考虑了产前皮质类固醇在缺乏来自随机对照试验的高质量数据的特殊人群中的作用，例如糖尿病、多胎妊娠和围产期。